Laurel Wealth Advisors, Inc. Arrowhead Pharmaceuticals, Inc. Transaction History
Laurel Wealth Advisors, Inc.
- $1.01 Billion
- Q4 2022
A detailed history of Laurel Wealth Advisors, Inc. transactions in Arrowhead Pharmaceuticals, Inc. stock. As of the latest transaction made, Laurel Wealth Advisors, Inc. holds 6,947 shares of ARWR stock, worth $136,369. This represents 0.03% of its overall portfolio holdings.
Number of Shares
6,947
Previous 7,327
5.19%
Holding current value
$136,369
Previous $242,000
16.53%
% of portfolio
0.03%
Previous 0.03%
Shares
7 transactions
Others Institutions Holding ARWR
# of Institutions
294Shares Held
90.8MCall Options Held
155KPut Options Held
426K-
Black Rock Inc. New York, NY15.7MShares$308 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA12.2MShares$240 Million0.0% of portfolio
-
Avoro Capital Advisors LLC New York, NY8.89MShares$174 Million2.59% of portfolio
-
State Street Corp Boston, MA6.35MShares$125 Million0.01% of portfolio
-
Slate Path Capital LP New York, NY4.89MShares$95.9 Million1.49% of portfolio
About ARROWHEAD PHARMACEUTICALS, INC.
- Ticker ARWR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 105,849,000
- Market Cap $2.08B
- Description
- Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. The company's products in pipeline includes ARO-AAT, a RNA interference (RNAi) therapeutic candidate that is in Phase II clinical trial for the treatment of liver diseases associated with alpha-1 antitrypsin deficiency; ARO-APOC3, w...